GZMB and inflammatory bowel disease: Alternatively, the prediction that granzyme B acts directly on CD8+ T cells in CD may represent a compensatory mechanism by which CD8+ T cells can attenuate the damage and inflammation caused by cytolytic cells in the setting of IBD.